Published December 19, 2013
Dr. Paul Sylvester, Pfizer Endowed Professor of Pharmacology and Director of Graduate
Studies and Research at the University of Louisiana at Monroe, recently traveled to
Cartegena, Colombia and Stuttgart, Germany to present his groundbreaking cancer research.
“The purpose of the trip [to Cartegena was] to give a presentation on our current
research related to tocotrienols—a rare form of Vitamin E that displays potent anticancer
activity,” Sylvester said.
During Sylvester’s trip to the University of Hohenheim in Stuttgart, Germany, Sylvester
was invited to speak to both undergraduate and graduate students about the anticancer
actions of tocotrienols.
Sylvester hopes to continue to present internationally in the hopes that he can establish
research collaborations with faculty at the universities around the world.
Sylvester is a member of several scientific, professional and honorary societies including
the American Association of Cancer Research (AACR), and The Endocrine Society, Society
for Experimental Biology and Medicine.
His research interests include the relationship between nutrition and breast cancer
growth and development, and the effects of various forms of vitamin E on breast cancer
cells.
In 2011, Sylvester was part of a research team which earned a patent for their discovery
of anti-cancer prototype compounds, which are found in the waxy substance on fresh
tobacco leaves and which show potential for controlling metastic breast and prostate
cancers.
Sylvester received his B.S. from Western Michigan University, Ph.D. from Michigan
State University, and completed his Postdoctoral Training at Roswell Park Cancer Institute
in Buffalo, NY.
He has taught at ULM for over 15 years.
